Prolonged basiliximab use as an alternative to calcineurin inhibition to allow renal recovery late after heart transplantation. [electronic resource]
Producer: 20090213Description: 1043-5 p. digitalISSN:- 1557-3117
- Acute Kidney Injury -- etiology
- Adult
- Antibodies, Monoclonal -- therapeutic use
- Antigens, CD -- blood
- Basiliximab
- Calcineurin -- adverse effects
- Cardiomyopathies -- surgery
- Drug Administration Schedule
- Female
- Graft Rejection -- prevention & control
- Graft Survival -- drug effects
- Heart Arrest -- etiology
- Heart Transplantation -- immunology
- Humans
- Immunosuppressive Agents -- therapeutic use
- Interleukin-2 Receptor alpha Subunit -- blood
- Kidney -- drug effects
- Postoperative Complications -- diagnosis
- Recombinant Fusion Proteins -- therapeutic use
- Treatment Outcome
- Ventricular Dysfunction, Right -- diagnosis
- Waiting Lists
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.